Published in Addict Behav on January 01, 1985
Effects of an Internet-based voucher reinforcement program for smoking abstinence: a feasibility study. J Appl Behav Anal (2005) 2.04
The effectiveness of financial incentives for health behaviour change: systematic review and meta-analysis. PLoS One (2014) 1.64
beta2-Nicotinic acetylcholine receptor availability during acute and prolonged abstinence from tobacco smoking. Arch Gen Psychiatry (2009) 1.53
Contingent payment procedures for smoking reduction and cessation. J Appl Behav Anal (1986) 1.45
Effects of internet-based voucher reinforcement and a transdermal nicotine patch on cigarette smoking. J Appl Behav Anal (2007) 1.22
Contingency management in the 21st century: technological innovations to promote smoking cessation. Subst Use Misuse (2011) 1.21
Sex differences in availability of β2*-nicotinic acetylcholine receptors in recently abstinent tobacco smokers. Arch Gen Psychiatry (2012) 1.17
Contingency management for smoking cessation: enhancing feasibility through use of immunoassay test strips measuring cotinine. Nicotine Tob Res (2008) 1.12
The use of financial incentives in promoting smoking cessation. Prev Med (2012) 1.08
Contingency management and motivational enhancement: a randomized clinical trial for college student smokers. Nicotine Tob Res (2009) 1.01
Duration effects in contingency management treatment of methamphetamine disorders. Addict Behav (2013) 0.99
Effects of contingency management and bupropion on cigarette smoking in smokers with schizophrenia. Psychopharmacology (Berl) (2011) 0.95
Brain β2*-nicotinic acetylcholine receptor occupancy after use of a nicotine inhaler. Int J Neuropsychopharmacol (2010) 0.89
Contingent vouchers and motivational interviewing for cigarette smokers in residential substance abuse treatment. J Subst Abuse Treat (2015) 0.82
CHRNA4 and ANKK1 Polymorphisms Influence Smoking-Induced Nicotinic Acetylcholine Receptor Upregulation. Nicotine Tob Res (2016) 0.75
A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N Engl J Med (2000) 6.65
Moderate- vs high-dose methadone in the treatment of opioid dependence: a randomized trial. JAMA (1999) 5.29
A reinforcement-based therapeutic workplace for the treatment of drug abuse: six-month abstinence outcomes. Exp Clin Psychopharmacol (2001) 4.46
Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry (1997) 3.67
Clinical pharmacology of buprenorphine: ceiling effects at high doses. Clin Pharmacol Ther (1994) 2.90
Providing medical care to methadone clinic patients: referral vs on-site care. Am J Public Health (1994) 2.79
A clinical trial of buprenorphine: comparison with methadone in the detoxification of heroin addicts. Clin Pharmacol Ther (1988) 2.32
Voucher-based reinforcement of cocaine abstinence in treatment-resistant methadone patients: effects of reinforcement magnitude. Psychopharmacology (Berl) (1999) 2.30
Induction of opioid-dependent individuals onto buprenorphine and buprenorphine/naloxone soluble-films. Clin Pharmacol Ther (2011) 1.74
Acute administration of buprenorphine in humans: partial agonist and blockade effects. J Pharmacol Exp Ther (1995) 1.73
Comparison of buprenorphine and methadone in the treatment of opioid dependence. Am J Psychiatry (1994) 1.70
Buprenorphine: dose-related blockade of opioid challenge effects in opioid dependent humans. J Pharmacol Exp Ther (1988) 1.68
Enadoline, a selective kappa opioid agonist: comparison with butorphanol and hydromorphone in humans. Psychopharmacology (Berl) (2001) 1.68
Voucher-based reinforcement of opiate plus cocaine abstinence in treatment-resistant methadone patients: effects of reinforcer magnitude. Exp Clin Psychopharmacol (2001) 1.62
Contingent reinforcement for carbon monoxide reduction: within-subject effects of pay amount. J Appl Behav Anal (1984) 1.58
A placebo controlled clinical trial of buprenorphine as a treatment for opioid dependence. Drug Alcohol Depend (1995) 1.54
Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans. Psychopharmacology (Berl) (2001) 1.53
Effects of a restricted work-site smoking policy on employees who smoke. Am J Public Health (1994) 1.52
Comparative effects of alcohol and marijuana on mood, memory, and performance. Pharmacol Biochem Behav (1997) 1.51
The effects of a cooperation contingency on behavior in a continuous three-person environment. J Exp Anal Behav (1976) 1.50
Desire to smoke during spaced smoking intervals. Psychopharmacology (Berl) (1995) 1.45
Contingent payment procedures for smoking reduction and cessation. J Appl Behav Anal (1986) 1.45
Effects of buprenorphine and methadone in methadone-maintained subjects. Psychopharmacology (Berl) (1995) 1.42
Marijuana smoking: effect of varying delta 9-tetrahydrocannabinol content and number of puffs. J Pharmacol Exp Ther (1992) 1.42
Effects of naltrexone on response to intravenous cocaine, hydromorphone and their combination in humans. J Pharmacol Exp Ther (1996) 1.41
Enadoline and butorphanol: evaluation of kappa-agonists on cocaine pharmacodynamics and cocaine self-administration in humans. J Pharmacol Exp Ther (2001) 1.41
Effects of buprenorphine/naloxone in opioid-dependent humans. Psychopharmacology (Berl) (2001) 1.41
Dose-response effects of methadone in the treatment of opioid dependence. Ann Intern Med (1993) 1.41
Cigarette brand-switching: effects on smoke exposure and smoking behavior. J Pharmacol Exp Ther (1988) 1.41
Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers. Psychopharmacology (Berl) (2000) 1.36
Validity of intravenous drug abusers' self-reported changes in HIV high-risk drug use behaviors. Drug Alcohol Depend (1995) 1.36
Reducing drug use among methadone maintenance clients: contingent reinforcement for morphine-free urines. Addict Behav (1980) 1.35
Buprenorphine versus methadone in the treatment of opioid dependence: self-reports, urinalysis, and addiction severity index. J Clin Psychopharmacol (1996) 1.35
Attendance incentives for outpatient treatment: effects in methadone- and nonmethadone-maintained pregnant drug dependent women. Drug Alcohol Depend (1997) 1.30
Expired air carbon monoxide accumulation and elimination as a function of number of cigarettes smoked. Addict Behav (1980) 1.28
Antinociceptive, subjective and behavioral effects of smoked marijuana in humans. Drug Alcohol Depend (2000) 1.26
Cross-validation of a new procedure for early screening of smoking cessation medications in humans. Clin Pharmacol Ther (2010) 1.26
Facilitation of human tobacco self-administration by ethanol: a behavioral analysis. J Exp Anal Behav (1976) 1.26
Effects of tetrahydrocannabinol content on marijuana smoking behavior, subjective reports, and performance. Pharmacol Biochem Behav (1989) 1.25
Voucher-based reinforcement of attendance by unemployed methadone patients in a job skills training program. Drug Alcohol Depend (1996) 1.24
Contingent methadone delivery: effects on illicit-opiate use. Drug Alcohol Depend (1986) 1.23
Effect of methadone dose contingencies on urinalysis test results of polydrug-abusing methadone-maintenance patients. Drug Alcohol Depend (1986) 1.23
Human cigarette smoking: effects of puff and inhalation parameters on smoke exposure. J Pharmacol Exp Ther (1987) 1.22
Contingent reinforcement for benzodiazepine-free urines: evaluation of a drug abuse treatment intervention. J Appl Behav Anal (1982) 1.22
The role of behavioral contingency management in drug abuse treatment. NIDA Res Monogr (1984) 1.22
Nicotine-containing versus de-nicotinized cigarettes: effects on craving and withdrawal. Pharmacol Biochem Behav (1997) 1.22
Cost-effectiveness of treatment for drug-abusing pregnant women. Drug Alcohol Depend (1997) 1.21
Contingent reinforcement for reduced carbon monoxide levels in cigarette smokers. Addict Behav (1982) 1.20
Human cigarette smoking: manipulation of number of puffs per bout, interbout interval and nicotine dose. J Pharmacol Exp Ther (1982) 1.20
Drug discrimination in human postaddicts: agonist-antagonist opioids. J Pharmacol Exp Ther (1989) 1.19
One-, three-, and six-month outcomes after brief inpatient opioid detoxification. Am J Drug Alcohol Abuse (2001) 1.19
Predictors of discharges against medical advice from a short-term hospital detoxification unit. Drug Alcohol Depend (1999) 1.19
Experimental model of smoking re-exposure: effects on relapse. Psychopharmacology (Berl) (1992) 1.19
Reducing benzodiazepine self-administration with contingent reinforcement. Addict Behav (1979) 1.18
Buprenorphine effects in methadone-maintained volunteers: effects at two hours after methadone. J Pharmacol Exp Ther (1995) 1.15
Contingent methadone take-home doses reinforce adjunct therapy attendance of methadone maintenance patients. Drug Alcohol Depend (1994) 1.15
The effects of contingent payment and frequent workplace monitoring on smoking abstinence. Addict Behav (1989) 1.15
Use of methadone take-home contingencies with persistent opiate and cocaine abusers. J Subst Abuse Treat (1999) 1.14
Cigarette filter vent blocking: effects on smoking topography and carbon monoxide exposure. Pharmacol Biochem Behav (1986) 1.14
Alcohol and secobarbital effects as a function of familial alcoholism: extended intoxication and increased withdrawal effects. Alcohol Clin Exp Res (1991) 1.13
Antisocial personality disorder and HIV infection among intravenous drug abusers. Am J Psychiatry (1993) 1.13
The brief abstinence test: voucher-based reinforcement of cocaine abstinence. Drug Alcohol Depend (2000) 1.12
Reinforcement-based intensive outpatient treatment for inner city opiate abusers: a short-term evaluation. Drug Alcohol Depend (2000) 1.11
Early treatment time course of depressive symptoms in opiate addicts. J Nerv Ment Dis (1991) 1.11
Contingency management in methadone maintenance: effects of reinforcing and aversive consequences on illicit polydrug use. Drug Alcohol Depend (1988) 1.11
Onset, magnitude and duration of opioid blockade produced by buprenorphine and naltrexone in humans. Psychopharmacology (Berl) (1999) 1.10
Gradual dose taper following chronic buprenorphine. Am J Addict (2001) 1.10
Mecamylamine does not precipitate withdrawal in cigarette smokers. Psychopharmacology (Berl) (1996) 1.10
Methods for enhancing transition of substance dependent patients from inpatient to outpatient treatment. Drug Alcohol Depend (2001) 1.09
Buprenorphine versus methadone in the treatment of opioid-dependent cocaine users. Psychopharmacology (Berl) (1994) 1.07